These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 19013383

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The pathological changes of the orbital tissue in thyroid associated ophthalmopathy].
    Hei Y, Kang L, Li YY, Xiao LH.
    Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):423-6. PubMed ID: 18953897
    [Abstract] [Full Text] [Related]

  • 24. The challenge of orbital decompression in a patient with multiple autoimmune diseases and graves' orbitopathy: a case report and review of literature.
    Sellari-Franceschini S, Bartalena L, Seccia V.
    Orbit; 2010 Feb; 29(1):48-50. PubMed ID: 20302412
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Thyroid orbitopathy and diabetes].
    Cáp J.
    Vnitr Lek; 2007 May; 53(5):524-7. PubMed ID: 17642437
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
    Nguyen B, Gopinath B, Tani J, Wescombe L, Wall JR.
    Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
    [Abstract] [Full Text] [Related]

  • 31. Subconjunctival orbital fat prolapse and thyroid associated orbitopathy: a clinical association.
    Chatzistefanou KI, Samara C, Asproudis I, Brouzas D, Moschos MM, Tsianta E, Piaditis G.
    Clin Interv Aging; 2017 Aug; 12():359-366. PubMed ID: 28243072
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Changes of saccadic eye movements in thyroid-associated ophthalmopathy.
    Schworm HD, Bolzani R, Benassi M, Tallstedt L, Rydberg A, Lennerstrand G, Ygge J.
    Acta Ophthalmol; 2012 Dec; 90(8):713-20. PubMed ID: 21801340
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.
    Eckstein AK, Lösch C, Glowacka D, Schott M, Mann K, Esser J, Morgenthaler NG.
    Br J Ophthalmol; 2009 Aug; 93(8):1052-6. PubMed ID: 19221109
    [Abstract] [Full Text] [Related]

  • 38. Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy.
    Chen MH, Chen MH, Liao SL, Chang TC, Chuang LM.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):332-7. PubMed ID: 18284633
    [Abstract] [Full Text] [Related]

  • 39. [The endocrinological management of thyroid associated orbitopathy in relation to severity and activity of the disease].
    Michałek K, Waśko R, Sowiński J.
    Przegl Lek; 2004 Aug; 61(8):838-40. PubMed ID: 15789911
    [Abstract] [Full Text] [Related]

  • 40. Association between radioiodine therapy for Graves' hyperthyroidism and thyroid-associated ophthalmopathy.
    El-Kaissi S, Bowden J, Henry MJ, Yeo M, Champion BL, Brotchie P, Nicholson GC, Wall JR.
    Int Ophthalmol; 2010 Aug; 30(4):397-405. PubMed ID: 20405165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.